TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIAL

2015 ◽  
Vol 21 (7) ◽  
pp. 782-793 ◽  
Author(s):  
Robert C. Hood ◽  
Richard F. Arakaki ◽  
Carol Wysham ◽  
Ying G. Li ◽  
Julie A. Settles ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Glycemic Control ◽  
Insulin Therapy ◽  
High Dose ◽  
Treatment Approaches ◽  
Oral Agents

148-OR: IDegLira Improves Glycemic Control in Japanese Patients with Type 2 Diabetes (T2D) Uncontrolled on Premixed Insulin Therapy

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 148-OR ◽  
Author(s):  
HIROTAKA WATADA ◽  
BUE F. AGNER ◽  
ANKUR DOSHI ◽  
RANDI GRØN ◽  
MATTIS F. RANTHE ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Insulin Therapy ◽  
Japanese Patients ◽  
Premixed Insulin

scholarly journals Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents

Diabetes Care ◽  
2010 ◽  
Vol 33 (6) ◽  
pp. 1300-1303 ◽  
Author(s):  
J. B. Buse ◽  
G. Sesti ◽  
W. E. Schmidt ◽  
E. Montanya ◽  
C.-T. Chang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Once Daily ◽  
Oral Agents
Sign in / Sign up

Export Citation Format

Share Document